7459 MEDIPAL HOLDINGS CORPORATION - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

7459

TSE Prime

MEDIPAL HOLDINGS CORPORATION

2,911.5

JPY

-22.5

(-0.77%)

Feb 16, 2:58 pm JST

19.00

USD

Feb 16, 12:58 am EST

Result

PTS

outside of trading hours

2,912.6

Feb 16, 2:58 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	3,290,921	45,624	62,046	29,423	140.1	44	May 13, 2022	J-GAAP
Mar, 2023	3,360,008	48,972	65,122	38,806	184.8	46	May 12, 2023	J-GAAP
Mar, 2024	3,558,732	47,330	64,570	41,474	195.8	60	May 14, 2024	J-GAAP
Mar, 2025	3,671,328	55,609	65,255	40,279	193.2	62	May 13, 2025	J-GAAP
Mar, 2026 Guidance	3,785,000	52,000	69,000	34,500	168.5	64	May 13, 2025	J-GAAP
YoY	+3.1%	-6.5%	+5.7%	-14.3%	-12.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 14, 2020	ー	ー	ー	ー	42	J-GAAP
- - - -	Jul 31, 2020	3,218,000	43,000	57,000	30,000	42	J-GAAP
	Oct 30, 2020	3,207,000	32,000	46,000	22,800	42	J-GAAP
Results	May 13, 2021	3,211,125	38,576	52,968	23,926	42	J-GAAP
Mar, 2022	May 13, 2021	Available in future release
	Apr 28, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
Results	May 12, 2023
Mar, 2024	May 12, 2023
Results	May 14, 2024
Mar, 2025	May 14, 2024
	Apr 30, 2025
Results	May 13, 2025
Mar, 2026	May 13, 2025	3,785,000	52,000	69,000	34,500	64	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	1,073,015	+293.8	Available in future release
Mar, 2002	1,222,221	+13.9
Mar, 2003	1,274,502	+4.3
Mar, 2004	1,283,925	+0.7
Mar, 2005	1,665,815	+29.7
Mar, 2006	1,921,713	+15.4
Mar, 2007	2,166,762	+12.8
Mar, 2008	2,254,936	+4.1
Mar, 2009	2,463,569	+9.3
Mar, 2010	2,546,029	+3.3
Mar, 2011	2,662,821	+4.6
Mar, 2012	2,750,233	+3.3
Mar, 2013	2,810,959	+2.2
Mar, 2014	2,947,798	+4.9
Mar, 2015	2,872,905	-2.5
Mar, 2016	3,028,187	+5.4
Mar, 2017	3,063,900	+1.2
Mar, 2018	3,146,314	+2.7
Mar, 2019	3,181,928	+1.1
Mar, 2020	3,253,079	+2.2
Mar, 2021	3,211,125	-1.3
Mar, 2022	3,290,921	+2.5
Mar, 2023	3,360,008	+2.1
Mar, 2024	3,558,732	+5.9
Mar, 2025	3,671,328	+3.2
Mar, 2026 Guidance	3,785,000	+3.1	52,000	-6.5	69,000	+5.7	168.5	-12.8

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	3,558,732	47,330	1.33	7.14	2.36	2.03	195.8
Mar, 2025	3,671,328	55,609	1.51	6.60	2.22	2.03	193.2
Mar, 2026 Guidance	3,785,000	52,000	1.37	5.38	1.71	1.87	168.5

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	3,671,328	55,609	68,020	41,474	195.8
Fiscal Year	Mar, 2025	Mar, 2025	Mar, 2020	Mar, 2024	Mar, 2024

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	1,674,612	23,429	31,861	21,482	102.3	23	May 12, 2023	J-GAAP
Oct - Mar, 2023	1,779,743	26,699	35,271	24,320	114.8	30	May 14, 2024	J-GAAP
Oct - Mar, 2024	1,846,656	28,447	30,175	18,552	89.0	32	May 13, 2025	J-GAAP
Oct - Mar, 2025 Guidance	1,887,438	26,917	34,731	12,410	60.6	32	Nov 5, 2025	J-GAAP
YoY	+2.2%	-5.4%	+15.1%	-33.1%	-31.9%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	48,972	-23,348	16,146	-39,494	-43,541	193,561	11.32	J-GAAP
Mar, 2024	47,330	54,026	61,843	-7,817	-25,248	228,084	12.68	J-GAAP
Mar, 2025	55,609	57,196	60,559	-3,363	-25,947	259,337	14.21	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	2,714,915	37,215	50,240	28,286	133.2	77.8	Feb 5, 2024	J-GAAP
Apr - Dec, 2024	2,807,172	45,372	56,709	36,238	173.7	86.9	Feb 10, 2025	J-GAAP
Apr - Dec, 2025	2,911,667	43,183	61,313	37,414	181.5	88.9	Feb 9, 2026	J-GAAP
YoY	+3.7%	-4.8%	+8.1%	+3.2%	+4.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	843,817	10,115	14,330	13,188	62.3	1.2	May 14, 2024	J-GAAP
Apr - Jun, 2024	909,317	13,283	16,916	9,008	43.0	1.5	Aug 1, 2024	J-GAAP
Jul - Sep, 2024	915,355	13,879	18,164	12,719	60.9	1.5	Nov 1, 2024	J-GAAP
Oct - Dec, 2024	982,500	18,210	21,629	14,511	69.5	1.9	Feb 10, 2025	J-GAAP
Jan - Mar, 2025	864,156	10,237	8,546	4,041	19.4	1.2	May 13, 2025	J-GAAP
Apr - Jun, 2025	945,159	14,053	18,234	9,586	46.2	1.5	Aug 5, 2025	J-GAAP
Jul - Sep, 2025	952,403	11,030	16,035	12,504	60.5	1.2	Nov 5, 2025	J-GAAP
Oct - Dec, 2025	1,014,105	18,100	27,044	15,324	74.3	1.8	Feb 9, 2026	J-GAAP
YoY	+3.2%	-0.6%	+25.0%	+5.6%	+6.9%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	772,313	+0.4	Available in future release
Apr - Jun, 2021	824,877	+3.9
Jul - Sep, 2021	818,367	+3.0
Oct - Dec, 2021	864,026	+1.6
Jan - Mar, 2022	783,651	+1.5
Apr - Jun, 2022	838,328	+1.6
Jul - Sep, 2022	847,068	+3.5
Oct - Dec, 2022	882,022	+2.1
Jan - Mar, 2023	792,590	+1.1
Apr - Jun, 2023	886,737	+5.8
Jul - Sep, 2023	892,252	+5.3
Oct - Dec, 2023	935,926	+6.1
Jan - Mar, 2024	843,817	+6.5
Apr - Jun, 2024	909,317	+2.5
Jul - Sep, 2024	915,355	+2.6
Oct - Dec, 2024	982,500	+5.0
Jan - Mar, 2025	864,156	+2.4
Apr - Jun, 2025	945,159	+3.9
Jul - Sep, 2025	952,403	+4.0
Oct - Dec, 2025	1,014,105	+3.2	18,100	-0.6	27,044	+25.0	74.3	+6.9

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,014,105	18,210	27,044	15,324	74.3
Fiscal Year	Dec, 2025	Dec, 2024	Dec, 2025	Dec, 2025	Dec, 2025

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	2,673.62	32.8	1,709,658	561,357	414,723	ー	May 12, 2023	J-GAAP
Mar, 2024	2,858.57	33.4	1,799,127	600,349	439,315	ー	May 14, 2024	J-GAAP
Mar, 2025	2,979.39	33.9	1,824,984	619,564	463,071	ー	May 13, 2025	J-GAAP
Apr - Dec, 2025	3,132.44	31.8	2,019,371	641,205	479,381	ー	Feb 9, 2026	J-GAAP

MEDIPAL HOLDINGS CORPORATION(7459) Financial Results